ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm Doses First UK Participant in Phase 3 Trial
Published: 26/10/22, 09:35am (AEST)•4 pages